FundedIQ
Biotechnology

Adipo Therapeutics: Funding, Investors & Team (Oct 2026)

Adipo Therapeutic is a biotechnology company that develops polymer-based nanotherapeutics. Its nanotherapeutics utilizes adipocyte browning technique to convert energy-storing bad fat cells into energy-burning good fat cells to transform the treatment of obesity and type 2 diabetes, enabling patients to lose bodyweight naturally and restoring metabolic balance for millions of people living with diabetes.

adipotherapeutics.com LinkedIn West Lafayette, United States 1-10 employees
Total raised
$4.7M
Rounds
1
Latest
Undisclosed round
Dec 2024

Adipo Therapeutics has raised $4.7M across 1 funding round on record, the most recent an undisclosed round of $4.7M announced in Dec 2024.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Adipo Therapeutics Company Profile and Key Stats

Total funding raised
$4.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$4.7M in Dec 2024
Employees
1-10
reported band
Headquarters
West Lafayette, United States

Latest funding round on record: Dec 2024.

Adipo Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$4.7M

Adipo Therapeutics Founders and Leadership Team

Name
Role
Contact
Meng Deng
Founder
Locked

Contact details for the Adipo Therapeutics team: 1 of 1 has an email address on file.

Start 14-day free trial →

Adipo Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Adipo Therapeutics' latest round of $4.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Adipo Therapeutics in Biotechnology and West Lafayette

Companies Similar to Adipo Therapeutics

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Adipo Therapeutics Funding FAQs

What does Adipo Therapeutics do?

Adipo Therapeutic is a biotechnology company that develops polymer-based nanotherapeutics. Its nanotherapeutics utilizes adipocyte browning technique to convert energy-storing bad fat cells into energy-burning good fat cells to transform the treatment of obesity and type 2 diabetes, enabling patients to lose bodyweight naturally and restoring metabolic balance for millions of people living with diabetes.

How much funding has Adipo Therapeutics raised?

Adipo Therapeutics has raised $4.7M across 1 round on record. The most recent is an undisclosed round of $4.7M announced in Dec 2024.

When did Adipo Therapeutics last raise funding?

Adipo Therapeutics' most recent funding round on record is an undisclosed round of $4.7M, announced in Dec 2024.

Who founded Adipo Therapeutics?

FundedIQ lists Meng Deng (Founder) at Adipo Therapeutics.

Where is Adipo Therapeutics headquartered?

Adipo Therapeutics is based in West Lafayette, Indiana, United States.

How many employees does Adipo Therapeutics have?

Adipo Therapeutics is in the 1-10 employee band.

How does Adipo Therapeutics' funding compare to other Biotechnology startups?

Adipo Therapeutics' latest round of $4.7M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Adipo Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adipo Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.